Monogram Orthopedics Stock: Zimmer Biomet Deal Explained

If you are looking up Monogram Orthopedics stock, the most important fact is that it no longer trades. The company behind the ticker MGRM, which changed its name from Monogram Orthopaedics, Inc. to Monogram Technologies Inc. in May 2024, has been acquired by Zimmer Biomet, and its shares have ceased trading. Here is what happened, what shareholders received, and the key numbers from the stock’s final stretch on the market.

Key takeaways

• Monogram Orthopaedics, Inc. changed its name to Monogram Technologies Inc. in May 2024, and its stock traded on the Nasdaq under the ticker MGRM.
• Zimmer Biomet announced on October 7, 2025 that it completed its acquisition of Monogram Technologies.
• Each outstanding Monogram share was converted into the right to receive $4.04 in cash and up to $12.37 in cash, and the shares ceased trading.
• Before delisting, MGRM last closed at $6.00 with a market capitalization of approximately $244.2 million, and its 52-week range ran from 1.92 to 6.43.

What happened to Monogram Orthopedics stock?

Monogram built its reputation in orthopedic medical technology and listed on the Nasdaq, where it traded under the symbol MGRM. According to Yahoo Finance, the company was formerly known as Monogram Orthopaedics, Inc. and changed its name to Monogram Technologies Inc. in May 2024, which is why older coverage and newer market data use different names for the same business.

The standalone story ended when Zimmer Biomet, a global medical technology leader listed on the NYSE and SIX under the symbol ZBH, announced on October 7, 2025 that it had completed its acquisition of Monogram Technologies. With the deal closed, Monogram stopped trading as an independent public company.

What shareholders received

According to Zimmer Biomet’s completion announcement, each outstanding share of Monogram common stock was converted into the right to receive $4.04 in cash and up to $12.37 in cash, and the shares ceased trading. The wording matters: the first component is a stated cash amount, while the additional amount is described as up to $12.37, which is a ceiling rather than a guaranteed payment. The announcement summary does not spell out the conditions that determine how much of that additional amount gets paid, so former shareholders should read the full announcement or ask their broker for the specifics of their payout.

Monogram’s final market numbers

Market data captured around the close of the deal shows where the stock finished. StockTitan reported that MGRM last closed at $6.00, with a market capitalization of approximately $244.2 million, and Robinhood’s quote page showed the same $6.00 price. Per stockanalysis.com, the stock’s 52-week range ran from 1.92 to 6.43.

It is also worth being clear about what kind of company Monogram was financially. One market-data profile described it as a pre-revenue medical device company and notes that the MGRM ticker is no longer active. That is a useful corrective for anyone who saw Monogram framed as an established, revenue-generating business.

What Monogram built

Monogram’s appeal to investors came from its technology portfolio rather than its sales. The company focused on 3D-printed custom orthopedic implants, precision-engineered surgical instruments, computer-assisted surgical navigation systems, and patient-specific anatomical modeling technologies, pairing materials science with biomechanical engineering to support personalized surgical care.

What this means for investors now

You can no longer buy Monogram Orthopedics or Monogram Technologies stock: the ticker is inactive and the shares ceased trading when the acquisition closed. If you held shares through the closing, your position was converted into the right to receive the cash consideration described above, and your broker is the right place to confirm how and when any payments reach your account.

If you were following Monogram as a way to invest in orthopedic surgical technology, the practical lessons carry over to any small-cap medical device stock: check whether a ticker is still active before acting on older coverage, read the acquirer’s official announcements for the exact per-share terms of any deal, and treat secondhand financial figures with caution until you can trace them to a primary source such as a company filing or an official press release.

Frequently asked questions

What happened to my Monogram Technologies stock?

Zimmer Biomet completed its acquisition of Monogram Technologies. Per the acquirer’s announcement, each outstanding share was converted into the right to receive $4.04 in cash and up to $12.37 in cash, and the shares ceased trading.

Who acquired Monogram Orthopedics?

Zimmer Biomet, a global medical technology leader, announced the completed acquisition on October 7, 2025. Monogram Orthopaedics had already renamed itself Monogram Technologies Inc. in May 2024, so coverage of the deal uses the newer name.

Is MGRM still trading?

No. The ticker is no longer active, and the shares ceased trading when the acquisition closed.

What was Monogram’s last share price?

MGRM last closed at $6.00, with a market capitalization of approximately $244.2 million. Its 52-week range was 1.92 to 6.43.